Keol-C

Oxygen, the active ingredient in Keol-C, is a medical gas presented as a supplemental oxygen source for inhalation use. It is employed to increase arterial oxygen tension, supporting patients with respiratory insufficiency, hypoxaemia, or during peri‑operative care.

GNH USA supplies Keol-C as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to EU quality standards, provides full regulatory documentation, and ensures reliable logistics and dedicated technical support for global distribution.

Keol‑C provides supplemental oxygen for conditions affecting the respiratory system and oxygenation.

Acute hypoxemia: restores adequate arterial oxygen levels to prevent tissue hypoxia. Chronic obstructive pulmonary disease (COPD) exacerbations: improves oxygen saturation and reduces work of breathing. Peri‑operative care: maintains optimal oxygenation during anesthesia and surgery. Carbon monoxide poisoning: displaces carbon monoxide from hemoglobin and accelerates recovery.

Oxygen therapy may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects: - Nasal dryness or irritation - Cough - Headache - Dizziness - Fatigue - Mild chest discomfort

Serious or Rare Side Effects: - Pulmonary oxygen toxicity leading to inflammation - Seizures due to hyperoxia - Retinopathy of prematurity in neonates - Fire or explosion risk in the presence of flammable materials

When using Keol‑C, several safety measures and patient assessments are recommended.

- Assess oxygen saturation before initiation: use pulse oximetry to confirm need. - Adjust flow rate to target SpO₂: maintain recommended clinical range. - Monitor for signs of hyperoxia: watch for visual changes or respiratory distress. - Avoid use with open flames or smoking: oxygen supports combustion. - Use appropriate delivery device: ensure correct fitting of mask or cannula. - Store at ambient temperature: keep cylinders in a well‑ventilated, dry area away from heat sources and open flames.

Oxygen can interact with certain agents and environmental factors, requiring careful management.

Major Interactions (Avoid): - Flammable anesthetic gases: avoid high‑concentration oxygen with nitrous oxide or volatile agents. - Methoxyflurane: contraindicated due to increased nephrotoxicity risk.

Moderate Interactions (Monitor Closely): - Bronchodilators: monitor for enhanced respiratory response. - Sedatives and opioids: observe for additive respiratory depression. - Bleomycin chemotherapy: watch for increased pulmonary toxicity. - High‑concentration nitric oxide therapy: assess for oxidative stress.